These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20123038)

  • 1. Need of stratifying patients according to severity of underlying liver disease for hepatocellular carcinoma patients undergoing systemic therapy trials.
    Yeo W; Mo FK; Hui P; Chan SL
    Contemp Clin Trials; 2010 Mar; 31(2):135. PubMed ID: 20123038
    [No Abstract]   [Full Text] [Related]  

  • 2. Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial.
    Rimassa L; Santoro A
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):739-45. PubMed ID: 19496710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma.
    Muto Y; Moriwaki H; Saito A
    N Engl J Med; 1999 Apr; 340(13):1046-7. PubMed ID: 10189289
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemotherapy of hepatocellular carcinoma].
    Okada S
    Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):2028-31. PubMed ID: 8586926
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.
    Wörns MA; Weinmann A; Pfingst K; Schulte-Sasse C; Messow CM; Schulze-Bergkamen H; Teufel A; Schuchmann M; Kanzler S; Düber C; Otto G; Galle PR
    J Clin Gastroenterol; 2009; 43(5):489-95. PubMed ID: 19247201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sorafenib in hepatocellular carcinoma: separating the hype from the hope.
    Kelley RK; Venook AP
    J Clin Oncol; 2008 Dec; 26(36):5845-8. PubMed ID: 19029408
    [No Abstract]   [Full Text] [Related]  

  • 7. Tamoxifen does not improve overall survival in people with advanced-stage hepatocellular carcinoma.
    Chow PK
    Cancer Treat Rev; 2005 Oct; 31(6):491-5. PubMed ID: 16214294
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatocellular carcinoma: treatment of 23 cases].
    Honório R; Gil JZ; Giovanoni M; Francisco Júnior J; Lustre W; Triviño T; Forones NM
    Arq Gastroenterol; 1999; 36(2):68-71. PubMed ID: 10511884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorafenib for recurrent hepatocellular carcinoma after liver transplantation.
    Yoon DH; Ryoo BY; Ryu MH; Lee SG; Hwang S; Suh DJ; Lee HC; Kim TW; Ahn CS; Kim KH; Moon DB; Kang YK
    Jpn J Clin Oncol; 2010 Aug; 40(8):768-73. PubMed ID: 20494947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Liver resection. I].
    Oldhafer KJ; Stavrou GA
    Zentralbl Chir; 2006 Oct; 131(5):W54-66; quiz W67-8. PubMed ID: 17089283
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of intraarterial infusion chemotherapy on liver function in patients with hepatocellular carcinoma].
    Abe K; Sugata F; Takizawa K; Yoshiba M; Takagi T; Higashi S; Kuniyasu Y
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1898-902. PubMed ID: 1652227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant hepatoma.
    van Dyk JJ
    Proc Mine Med Off Assoc SA; 1975; 55(421):19-20. PubMed ID: 209446
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy in hepatocellular carcinoma.
    Okada S
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1259-63. PubMed ID: 9730385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic therapy for hepatocellular carcinoma.
    Thomas MB
    Cancer J; 2008; 14(2):123-7. PubMed ID: 18391618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices.
    Amitrano L; Guardascione MA; Bennato R; Manguso F; Balzano A
    J Hepatol; 2005 Jun; 42(6):820-5. PubMed ID: 15885352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatocellular carcinoma].
    Kondo S; Ueno H; Morizane C; Okusaka T
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1219-23. PubMed ID: 20647702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic therapies in hepatocellular carcinoma.
    Wörns MA; Weinmann A; Schuchmann M; Galle PR
    Dig Dis; 2009; 27(2):175-88. PubMed ID: 19546557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of hepatocellular carcinoma patients with extrahepatic metastases.
    Okusaka T; Okada S; Ishii H; Nose H; Nagahama H; Nakasuka H; Ikeda K; Yoshimori M
    Hepatogastroenterology; 1997; 44(13):251-7. PubMed ID: 9058154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to overcome multidrug resistance in chemotherapy for advanced hepatocellular carcinoma.
    Ryu SH; Chung YH
    Liver Int; 2010 Apr; 30(4):496-8. PubMed ID: 20456038
    [No Abstract]   [Full Text] [Related]  

  • 20. Absence of symptom and intact liver function are positive prognosticators for patients undergoing radiotherapy for lymph node metastasis from hepatocellular carcinoma.
    Kim K; Chie EK; Kim W; Kim YJ; Yoon JH; Lee HS; Ha SW
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):729-34. PubMed ID: 20171806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.